Autor: |
Ruth Riisnaes, Arul M. Chinnaiyan, Pasquale Rescigno, Bora Gurel, Susana Miranda, Kevin Kelly, Daniel Nava Rodrigues, Nina Tunariu, Adam Sharp, Diletta Bianchini, Maialen Barrero, Zafeiris Zafeiriou, Colin C. Pritchard, Alec Paschalis, Wei Yuan, Robert Chandler, Joaquin Mateo, Johann S. de Bono, Antonella Petremolo, Semini Sumanasuriya, Suzanne Carreira |
Rok vydání: |
2018 |
Předmět: |
|
Zdroj: |
European Urology |
ISSN: |
1873-7560 |
Popis: |
Platinum-based regimens have not been proved to increase survival from advanced prostate cancer (PCa). Incontrovertible evidence that a proportion of prostate cancers have homologous recombination DNA (HRD) repair defects, and that such genomic aberrations are synthetically lethal with both poly(ADP)-ribose polymerase inhibition and platinum, has increased interest in the utilisation of these drugs against a subset of these diseases. Here in we report three patients with advanced castration-resistant PCa with HRD defects having exceptional responses to carboplatin. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|